Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeckTAR-IN: cDNA Biomarker in Head and Neck Carcinoma
NCT07178847Recruiting
- Sponsor
- Centre Jean Perrin
- Start
- Oct 2025
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Jean Perrin. Primary endpoint: cDNA detection and objective response 3 months after the end of chemoradiotherapy. Started Oct 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07178847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07178847.